Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy
NCT07473518 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2550
Last updated 2026-03-16
Summary
This study aims to define the optimal surveillance strategy for children exposed to radiotherapy by assessing the incidence, risk factors, and timing of thyroid nodules and differentiated thyroid cancer. It also investigates the genetic features of thyroid tumors in this population to identify predictive biomarkers of onset, malignancy, and aggressiveness. Ultimately, the goal is to support more personalized management, including tailored surgery and targeted therapies.
Conditions
- Thyroid Carcinoma
- Pediatric Cancer
Sponsors & Collaborators
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
lead OTHER
Eligibility
- Min Age
- 10 Years
- Max Age
- 43 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-30
- Primary Completion
- 2026-07-30
- Completion
- 2027-07-30
Countries
- Italy
Study Locations
More Related Trials
-
Hyperthyroid Follow-Up Study
NCT02989103 ·Status: COMPLETED
-
Study of Clinical Outcomes of Thyroid Cancer
NCT04031339 ·Status: UNKNOWN
-
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
NCT01837745 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Multicenter Study Differentiated Thyroid Carcinoma
NCT00144079 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Surgical Outcomes of Thyroid Carcinoma in Children and Adolescents
NCT06592118 ·Status: COMPLETED
-
Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation
NCT02824016 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
NCT06779747 ·Status: RECRUITING
-
Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)
NCT02156362 ·Status: UNKNOWN ·Phase: NA
-
The Incidence and Risk Factors of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer With Long Term Follow up
NCT03699098 ·Status: COMPLETED ·Phase: NA
-
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
NCT00415233 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
NCT01074684 ·Status: COMPLETED
-
I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer
NCT01704586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
NCT04290663 ·Status: RECRUITING ·Phase: PHASE3
-
Thyroid Uptake Quantification on a New Generation of Gamma Camera
NCT05049551 ·Status: COMPLETED
-
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
NCT00389441 ·Status: COMPLETED ·Phase: PHASE2
-
PET-TC in Thyroid Evaluation
NCT06852144 ·Status: ENROLLING_BY_INVITATION
-
Active Surveillance of Papillary Thyroid Microcarcinoma
NCT02609685 ·Status: RECRUITING ·Phase: NA
-
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
NCT03841617 ·Status: RECRUITING ·Phase: PHASE2
-
The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter
NCT01384786 ·Status: COMPLETED
-
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
NCT06087068 ·Status: RECRUITING ·Phase: PHASE2
-
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
NCT06134830 ·Status: NOT_YET_RECRUITING
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013 ·Status: RECRUITING
-
Evaluation of Thyroid Exposure to Radiation Doses During Paediatric Cardiac Catheterisations Performed for Diagnosis or the Treatment of Congenital Heart Disease
NCT01693796 ·Status: COMPLETED ·Phase: NA
-
Block-replacement Therapy During Radioiodine Therapy
NCT00150124 ·Status: COMPLETED ·Phase: PHASE4